1ISG-020 Market access in the eu, do we have enough evidence?

BACKGROUND: The European Medicines Agency (EMA) is responsible for the scientific evaluation of medicines for use in the European Union (EU), providing a scientific opinion on the granting of EU-wide marketing authorisations. PURPOSE: We conducted a retrospective analysis of new active substances (N...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Hosp Pharm
Auteurs principaux: Lluch, T Gómez, Fuentes, MD Fraga, Aroyo, P Araque, Dongil, C Notario, Gámez, JC Valenzuela, Benito, M Heredia
Format: Artigo
Langue:Inglês
Publié: BMJ Group 2018
Sujets:
Section 1: Introductory statements and governance
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535274/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.20
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires